Nanox (NASDAQ: NNOX) has entered into a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to penetrate Costa Rica's public healthcare system, as SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This milestone marks Nanox's third Latin American market this year, following Argentina and Peru, underscoring the company's strategic focus on expanding into emerging markets where access to advanced medical imaging is often limited.
The deal matters because it signals Nanox's growing traction in Latin America and its ability to execute on its vision of driving the world's transition to preventive health care. By partnering with a well-established distributor like SOLME, Nanox gains immediate credibility and access to Costa Rica's public hospital network. The CCSS is the primary provider of hospital services in Costa Rica, and its adoption of the Nanox.ARC could serve as a proof point for other public health systems in the region. The initial six-month proof-of-concept period allows for real-world validation of the technology, which could accelerate full registration and broader adoption.
Nanox is focused on delivering an integrated, end-to-end medical imaging and healthcare services platform. The Nanox ecosystem includes the Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The Costa Rica agreement is a concrete step toward that goal, potentially improving early detection of disease and patient outcomes in a market where advanced imaging may be underutilized. For investors, the news demonstrates Nanox's ability to secure distribution partners and navigate regulatory processes in new geographies, which is critical for revenue growth and market expansion. The full press release can be viewed at https://ibn.fm/C77lJ. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer.
